References
- Reichlin S.N. Eng. J. Med. 1983; 309(24)1495–1501, 1556–1563
- Kompella U.B, Lee V.H.L. Peptide and Protein Drug Delivery, V.H.L. Lee. Marcel Dekker, Inc., New York 1991; 391–484
- Bhatt N.P., Patel K., Borchardt R.T. Chemical pathways of peptide degradation. I. Deamidation of adrenocorticotropic hormone. Pharm. Res. 1990; 7(6)593–599
- Lee K.C., Lee Y.J., Song H.M., Chun C.J., DeLuca P.P. Degradation of synthetic salmon calcitonin in aqueous solution. Pharm. Res. 1992; 9(11)1521–1523
- Helm V.J., Müller B.W. Stability of gonadorelin and triptorelin in aqueous solution. Pharm. Res. 1990; 7(12)1253–1256
- Hoitink M.A., Beijnen J.H., Bult A., Houwen van der O.A.G.J., Nijholt J., Underberg W.J.M. Degradation kinetics of gonadorelin in aqueous solution. J. Pharm. Sci. 1996; 85(10)1053–1059
- Brange J., Langkjær L., Havelund S., Vølund A. Chemical stability of insulin. 1. Hydrolytic degradation during storage of pharmaceutical preparations. Pharm. Res. 1992; 9(6)715–726
- Powell M.F., Sanders L.M., Rogerson A., Si V. Parenteral peptide formulations: chemical and physical properties of native luteinizing hormone-releasing hormone (LHRH) and hydrophobic analogues in aqueous solution
- Johnson D.M, Pritchard R.A., Taylor W.F., Conley D., Zuniga G., McGreevy K.G. Degradation of the LH-RH analog nafarelin acetate in aqueous solution. Int. J. Pharm. 1986; 31: 125–129
- Tsuda T., Uchiyama M., Sato T., Yoshino H., Tsuchiya Y., Ishikawa S., Ohmae M., Watanabe S., Miyake Y. Mechanism and kinetics of secretin degradation in aqueous solution. J. Pharm. Sci. 1990; 79(3)223–227
- Krishnamoorthy R., Mitra A.K. Kinetics and mechanism of degradation of a cyclic hexapeptide (somatostatin analogue) in aqueous solution. Pharm. Res. 1992; 9(10)1314–1320
- Pourrat H., Barthomeuf C., Pourrat A., Cottier P.-E., Ibrahim H. Stabilization of octastatin a somatostatin analogue. Preparation of freeze-dried products for parenteral injection. Biol. Pharm. Bull. 1995; 18(5)766–771
- Jang S.W., Woo B.H., Lee J.T., Moon S.C., Lee K.C., DeLuca P.P. Stability of octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution. Pharmaceutical Development and Technology 1997; 2(4)409–414
- Montoro J.B., Galard R., Catalan R., Martinez J., Salvador P., Sabin P. Stability of somatostatin in total parenteral nutrition. Pharm. Weekbl. Sci. 1990; 12(6)240–242
- Merck A.G. Tables for the Chemical Laboratory. DarmstadtGermany
- Herrmann J., Bodmeier R. Somatostatin containing biodegradable microspheres prepared by a modified solvent evaporation method based on W/O/W-multiple emulsions. Int. J. Pharm. 1995; 126: 129–138
- Patel K., Borchardt R.T. Chemical pathways of peptide degradation. II Deamidation of an asparaginyl residue in a model hexapeptide. Pharm. Res. 1990; 7(6)593–599